By developing murine and human IL-2 orthogonal systems, they demonstrated a controlled activation of IL-2-dependent signaling pathways, providing insights into potential therapeutic strategies for both autoimmune diseases and cancer [249]. The gene discussed is IL2; the disease is cancer.